| NCT00145249 | National Institute of Allergy and Infectious Diseases (NIAID) | Cryptococcal Meningitis | 2005-05 | PHASE2 |
| NCT00003938 | European Organisation for Research and Treatment of Cancer - EORTC | Cancer | 1999-06 | PHASE3 |
| NCT00002742 | Aronex Pharmaceuticals | Chronic Myeloproliferative Disorders|Infection|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes | 1996-01 | PHASE3 |
| NCT06977490 | Sichuan Huiyu Pharmaceutical Co., Ltd|Changsha King-eagle Med Technology Co., Ltd. | Invasive Fungal Infections|Neutropenic Fever|Visceral Leishmaniasis | 2025-05-13 | NA |
| NCT00002041 | Bristol-Myers Squibb | Candidiasis, Esophageal|HIV Infections | | NA |
| NCT00001646 | National Institute of Allergy and Infectious Diseases (NIAID) | Acquired Immunodeficiency Syndrome|Aspergillosis|HIV Infections|Immunologic Deficiency Syndromes|Neutropenia | 1997-08 | PHASE3 |
| NCT00832208 | Drugs for Neglected Diseases|Addis Ababa University | Visceral Leishmaniasis | 2009-04 | PHASE2 |
| NCT06449040 | Hospital Universitário Professor Edgard Santos|Instituto Gon?alo Muniz FIOCRUZ BA | Cutaneous Leishmaniasis, American | 2019-03-01 | PHASE1|PHASE2 |
| NCT00002305 | Pfizer | Meningitis, Cryptococcal|HIV Infections | | NA |
| NCT00467883 | Assistance Publique - H?pitaux de Paris|URC-CIC Paris Descartes Necker Cochin | Zygomycosis | 2007-06 | PHASE2 |
| NCT05108545 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Neutropenia and Fever | 2021-12-15 | PHASE3 |
| NCT02629419 | Matinas BioPharma Nanotechnologies, Inc. | Candidiasis, Chronic Mucocutaneous | 2016-09-27 | PHASE2 |
| NCT05707832 | CSPC Ouyi Pharmaceutical Co., Ltd. | Invasive Candidiasis|Invasive Aspergillosis | 2023-03-30 | PHASE3 |
| NCT00986713 | Capital Medical University | Invasive Pulmonary Aspergillosis | 2008-06 | PHASE4 |
| NCT00216346 | PATH|World Health Organization | Visceral Leishmaniasis | 2003-06 | PHASE3 |
| NCT00001065 | National Institute of Allergy and Infectious Diseases (NIAID)|Bristol-Myers Squibb | Candidiasis, Oral|HIV Infections | | PHASE2 |
| NCT05471063 | Peking Union Medical College Hospital|CSPC Ouyi Pharmaceutical Group Co., Ltd. | Cryptococcal Meningitis | 2022-08-22 | NA |
| NCT04532463 | University of Pharmacy, Yangon | Cryptococcal Meningitis | 2020-10-01 | |
| NCT02273661 | Poitiers University Hospital | Allergic Bronchopulmonary Aspergillosis | 2014-11-19 | PHASE2 |
| NCT05116059 | Peking Union Medical College Hospital | Invasive Fungal Disease | 2021-10-22 | |
| NCT00628719 | Banaras Hindu University | Visceral Leishmaniasis | 2008-02 | PHASE3 |
| NCT06447402 | Post Graduate Institute of Medical Education and Research, Chandigarh | Chronic Pulmonary Aspergillosis|CPA|Aspergilloma | 2024-06-03 | PHASE3 |
| NCT00002159 | Janssen, LP | HIV Infections|Histoplasmosis|Blastomycosis | | PHASE3 |
| NCT00047827 | Astellas Pharma Inc | Aspergillosis | 2002-12 | PHASE2 |
| NCT00002019 | Liposome | Meningitis, Cryptococcal|HIV Infections | | NA |
| NCT00523965 | Banaras Hindu University|Drugs for Neglected Diseases|Rajendra Memorial Research Institute of Medical Sciences | Leishmaniasis, Visceral | 2007-09 | PHASE3 |
| NCT00491426 | Duke University|Pediatric Pharmacology Research Units Network | Infection | 2006-01 | |
| NCT00421187 | Gilead Sciences | Febrile Neutropenia | 2007-03 | PHASE4 |
| NCT00163111 | Pfizer | Candidiasis | 1998-09 | PHASE3 |
| NCT04993222 | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | Bioequivalence | 2020-06-04 | PHASE1 |
| NCT04140461 | Shanghai Public Health Clinical Center | Cryptococcal Meningitis|HIV Infections | 2020-01-02 | PHASE3 |
| NCT00696969 | Drugs for Neglected Diseases | Visceral Leishmaniasis | 2008-06 | PHASE3 |
| NCT03327727 | Vical | Invasive Aspergillosis|Invasive Pulmonary Aspergillosis | 2018-02-20 | PHASE2 |
| NCT01615809 | Fundació Sant Joan de Déu|Ministry of Health, Spain | Invasive Pulmonary Aspergillosis|Lymphoblastic Leukaemia|Myeloblastic Leukaemia|Lymphoblastic Leukemia|Myeloblastic Leukemia | 2011-10 | PHASE2 |
| NCT03814343 | Mahidol University | Fungal Infection|Onychomycosis|Fungus, Nail | 2019-01-15 | PHASE4 |
| NCT03167957 | Matinas BioPharma Nanotechnologies, Inc. | Vulvovaginal Candidiases|Yeast Infection|Vulvovaginitis|Yeast Infection Vaginal|Candidiasis, Vulvovaginal | 2019-12 | PHASE2 |
| NCT07362667 | Qianfoshan Hospital | ABPA|Allergic Bronchopulmonary Aspergillosis|Allergic Bronchopulmonary Aspergillosis (ABPA)|Airway Clearance|Mucus Plug|Amphotericin B|Bronchoscope | 2026-01-10 | |
| NCT00624143 | All India Institute of Medical Sciences | Pediatric Acute Leukemia Induction | 2008-02 | PHASE3 |
| NCT00371995 | Banaras Hindu University|Rajendra Memorial Research Institute of Medical Sciences | Visceral Leishmaniasis | 2007-10 | PHASE2 |
| NCT00386997 | Gilead Sciences | Fungal Infection | 2006-11 | PHASE4 |
| NCT03636659 | Aurobindo Pharma Ltd|Axis Clinicals Limited | Visceral Leishmaniasis | 2018-05-02 | PHASE1 |
| NCT05913921 | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | Bioequivalence | 2023-06-02 | PHASE1 |
| NCT00002068 | Pfizer | Meningitis, Cryptococcal|HIV Infections | | NA |
| NCT04072640 | First Affiliated Hospital of Zhejiang University|Wenzhou Central Hospital | Cryptococcal Meningitis|HIV+AIDS | 2021-01-25 | EARLY_PHASE1 |
| NCT00418951 | M.D. Anderson Cancer Center | Acute Myelogenous Leukemia|Myelodysplastic Syndrome | 2006-11 | PHASE2 |
| NCT00003031 | European Organisation for Research and Treatment of Cancer - EORTC | Infection|Pulmonary Complications | 1997-06 | PHASE3 |
| NCT03187691 | Matinas BioPharma Nanotechnologies, Inc.|University of Cologne|The Clinical Trials Centre Cologne | Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia | 2019-08 | PHASE2 |
| NCT01652859 | Taiwan Liposome Company | Normal Healthy Subjects | 2012-02 | PHASE1 |
| NCT00076869 | Merck Sharp & Dohme LLC | Aspergillosis | 2003-01 | PHASE2 |
| NCT01310738 | University of Brasilia|Ministry of Health, Brazil|Drugs for Neglected Diseases|Conselho Nacional de Desenvolvimento Científico e Tecnológico | Visceral Leishmaniasis | 2011-02 | PHASE4 |
| NCT00847678 | Novartis Pharmaceuticals | Cryptococcal Meningitis | 2006-08 | PHASE2 |
| NCT00263315 | Erasmus Medical Center|Gilead Sciences|Nexstar Pharmaceuticals | Aspergillosis | 2000-01 | PHASE2|PHASE3 |
| NCT04031833 | Matinas BioPharma Nanotechnologies, Inc.|University of Minnesota | Cryptococcal Meningitis | 2019-10-24 | PHASE1|PHASE2 |
| NCT06376201 | Nanfang Hospital, Southern Medical University | Invasive Fungal Disease | 2024-04 | PHASE4 |
| NCT00000639 | National Institute of Allergy and Infectious Diseases (NIAID)|Washington University School of Medicine | Meningitis, Cryptococcal|HIV Infections | | NA |
| NCT01845727 | Drugs for Neglected Diseases | Cutaneous Leishmaniasis | 2014-02 | PHASE1|PHASE2 |
| NCT00001017 | Pfizer|National Institute of Allergy and Infectious Diseases (NIAID) | Meningitis, Cryptococcal|HIV Infections | | PHASE3 |
| NCT00002277 | Pfizer | Mycoses|HIV Infections | | PHASE3 |
| NCT00310505 | Banaras Hindu University | Visceral Leishmaniasis | 2003-01 | NA |
| NCT00235651 | University of Pittsburgh|Enzon Pharmaceuticals, Inc. | Lung Transplantation|Lung Diseases | 2005-10 | PHASE3 |
| NCT06640296 | Istituto Giannina Gaslini | Invasive Fungal Infections|Prophylaxis|Invasive Fungal Disease | 2023-12-12 | |
| NCT00008359 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) | Cancer | 2000-08 | PHASE3 |
| NCT07191756 | Qiu Ye|Guangzhou Medical University | Mucormycosis | 2025-05-15 | |
| NCT05642624 | Southeast University, China | Fungal Infection | 2019-02-28 | |
| NCT03112031 | Oxford University Clinical Research Unit, Vietnam|Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam|Cho Ray Hospital|University of Liverpool|University of Rochester|Liverpool School of Tropical Medicine | Meningitis Streptococcal|Hiv|Meningitis|Meningoencephalitis | 2017-10-10 | PHASE2 |
| NCT05814432 | Federal University of Health Science of Porto Alegre|Gilead Sciences|Financiadora de Estudos e Projetos|Sociedade Gaucha de Infectologia|Immuno-mycologics, Inc. (IMMY) | Disseminated Histoplasma Capsulatum Infection|AIDS and Infections|Immunosuppression|Fungal Infection | 2025-01-16 | PHASE3 |
| NCT06525389 | Duke University|National Institute of Allergy and Infectious Diseases (NIAID)|Pham Ngoc Thach University of Medicine|Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam|National Hospital for Tropical Diseases, Hanoi, Vietnam|Bach Mai Hospital|Gilead Sciences|Viatris Inc. | Talaromycosis | 2026-07-01 | PHASE3 |
| NCT00885703 | National Institute of Allergy and Infectious Diseases (NIAID) | Cryptococcal Meningitis|HIV Infections | 2010-04-16 | PHASE1|PHASE2 |
| NCT00148148 | University Hospital Muenster|Merck Sharp & Dohme LLC|Gilead Sciences | Hematopoietic Stem Cell Transplantation|Fungus Diseases | 2004-05 | PHASE2 |
| NCT00000708 | National Institute of Allergy and Infectious Diseases (NIAID) | Meningitis, Cryptococcal|HIV Infections | | NA |
| NCT01067443 | Drugs for Neglected Diseases|Gilead Sciences|Paladin Labs Inc. | Primary Visceral Leishmaniasis | 2010-03 | PHASE2 |
| NCT07530263 | Radboud University Medical Center|Gilead Sciences | Chronic Pulmonary Aspergillosis | 2026-05-01 | PHASE1 |
| NCT03196921 | Matinas BioPharma Nanotechnologies, Inc.|University of Minnesota | Cryptococcal Infections | 2018-10-01 | PHASE1|PHASE2 |
| NCT04502381 | Post Graduate Institute of Medical Education and Research, Chandigarh | Pulmonary Mucormycosis | 2020-07-01 | PHASE2 |
| NCT02025491 | Hospital Universitário Professor Edgard Santos | Disseminated Leishmaniasis | 2011-04 | PHASE3 |
| NCT06756191 | Bin Cao | Pulmonary Mucormycosis | 2025-01-10 | PHASE4 |
| NCT07532850 | Institute of Hematology & Blood Diseases Hospital, China | Invasive Fungal Infections | 2026-03-30 | |
| NCT01058174 | Astellas Pharma Inc | Liver Transplantation|Mycoses | 2009-12-15 | PHASE3 |
| NCT07185503 | Institute of Hematology & Blood Diseases Hospital, China | Mucormycosis in Hematologic Malignancies | 2025-03-25 | |
| NCT05541107 | Matinas BioPharma Nanotechnologies, Inc.|University of Minnesota | Cryptococcal Meningitis | 2023-01 | PHASE3 |
| NCT00177710 | University of Pittsburgh|Astellas Pharma US, Inc. | Lung Transplantation|Fungal Infections | 2006-01 | PHASE3 |
| NCT04267497 | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | Invasive Pulmonary Aspergillosis | 2019-10-18 | PHASE1 |
| NCT02686853 | Hui Bu | Cryptococcal Meningitis | 2016-01 | PHASE4 |
| NCT00002074 | Pfizer | Meningitis, Cryptococcal|HIV Infections | | NA |
| NCT00497601 | Banaras Hindu University | Visceral Leishmaniasis | 2007-02 | PHASE2 |
| NCT02136030 | TTY Biopharm | Cryptococcal Meningitis | 2011-02 | NA |
| NCT01122771 | Drugs for Neglected Diseases|Shaheed Suhrawardy Medical College and Hospital|International Centre for Diarrhoeal Disease Research, Bangladesh | Visceral Leishmaniasis | 2010-05 | PHASE3 |
| NCT00002316 | Alkermes, Inc. | Meningitis, Cryptococcal|HIV Infections | | PHASE1 |
| NCT04018417 | Cornea Research Foundation of America | Fuchs´ Endothelial Dystrophy | 2019-07-03 | PHASE2|PHASE3 |
| NCT00815516 | Astellas Pharma Global Development, Inc. | Candidiasis | 2013-02 | PHASE3 |
| NCT02011958 | Drugs for Neglected Diseases|Medecins Sans Frontieres, Netherlands|London School of Hygiene and Tropical Medicine|Addis Ababa University|Institute of Tropical Medicine, Belgium|Slotervaart Hospital|University of Gondar | Visceral Leishmaniasis | 2014-07 | PHASE3 |
| NCT00003315 | Medical Research Council | Infection | 1997-07 | PHASE3 |
| NCT00000776 | National Institute of Allergy and Infectious Diseases (NIAID) | Meningitis, Cryptococcal|HIV Infections | | PHASE2 |
| NCT05468372 | Post Graduate Institute of Medical Education and Research, Chandigarh | Mucormycosis; Pulmonary (Etiology) | 2022-07-01 | PHASE2 |
| NCT00876824 | Bharat Serums and Vaccines Limited|Ministry of Science and Technology | Leishmaniasis, Visceral | 2009-07 | PHASE3 |
| NCT00419770 | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center|Gilead Sciences|Astellas Pharma Inc|Novartis | Mucormycosis | 2007-10 | PHASE2 |
| NCT06926569 | Shanghai Public Health Clinical Center | HIV+AIDS-associated Talaromycosis | 2025-05-01 | NA |
| NCT01293643 | Merck Sharp & Dohme LLC | Vaginosis, Bacterial|Candidiasis, Vulvovaginal | 2010-05 | PHASE3 |
| NCT01945281 | Merck Sharp & Dohme LLC | Candidiasis, Invasive | 2014-01-15 | PHASE2 |
| NCT00451711 | Bayside Health|Gilead Sciences | Acute Myeloid Leukemia | 2007-05 | PHASE2 |
| NCT00002075 | Pfizer | Meningitis, Cryptococcal|HIV Infections | | NA |
| NCT01303549 | Fundacion SEIMC-GESIDA|Pfizer | Liver Disease|Fungal Infection | 2011-11 | PHASE4 |
| NCT00012467 | InterMune | Meningitis, Cryptococcal|HIV Infections | 2000-01 | PHASE2 |
| NCT04225195 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Invasive Candidiasis|Invasive Aspergillosis | 2020-01 | PHASE2 |
| NCT07463040 | Institute of Tropical Medicine, Belgium|London School of Hygiene and Tropical Medicine|Uppsala University|University of Stellenbosch|Armauer Hansen Research Institute, Ethiopia|Wollo University|Arba Minch University | Cutaneous Leihmaniasis | 2027-01-01 | PHASE3 |
| NCT06040489 | University of Brasilia | Leishmaniasis; Brazilian|Leishmaniasis, Mucocutaneous | 2022-06-22 | PHASE2|PHASE3 |
| NCT00106288 | Astellas Pharma Inc | Candidiasis | 2003-01 | PHASE3 |
| NCT07337720 | Southeast University, China | Aspergillosis Invasive | 2025-12-20 | NA |
| NCT04799236 | Fundacion Nacional de Dermatologia|Hospital Dermatologico de Jorochito|Centro Nacional de Enfermedades Tropicales CENETROP|ABF Foundation for Medical Research | Mucosal Leishmaniasis | 2021-04-01 | PHASE3 |
| NCT07559032 | Peking University People´s Hospital | Invasive Fungal Disease | 2026-04 | NA |
| NCT02971007 | Matinas BioPharma Nanotechnologies, Inc. | Vulvovaginitis|Yeast Infection|Yeast Infection Vaginal|Candidiasis, Vulvovaginal | 2016-11 | PHASE2 |
| NCT03511820 | TTY Biopharm | Neutropenia, Febrile | 2016-05-24 | |
| NCT00177684 | University of Pittsburgh|Enzon Pharmaceuticals, Inc. | Lung Transplantation|Fungal Infections | 2004-09 | PHASE3 |
| NCT01259713 | Gilead Sciences | Invasive Fungal Disease | 2011-04 | PHASE3 |
| NCT00936910 | Bill McGhee|Astellas Pharma Inc | Central Line Fungal Infections | 2006-09 | PHASE4 |
| NCT06178627 | Huashan Hospital | Cryptococcal Meningitis|Antifungal Agents | 2023-08-13 | PHASE4 |
| NCT06983665 | Sichuan Huiyu Pharmaceutical Co., Ltd | Invasive Fungal Infections|Neutropenic Fever|Visceral Leishmaniasis | 2025-05-25 | NA |